Biotech Analysis Central

• 10/7/2024

  **Underwhelming Profile: Third Harmonic**

• 10/7/2024

  **Septerna Seeks $100M IPO for Endocrine and Metabolic Drugs**

• 

  10/4/2024

  **Summit Therapeutics: Cancer Breakthrough Nears US Approval**

• 

  10/4/2024

  **Atacicept: A Breakthrough for IgAN Treatment**

• 

  10/4/2024

  **Best Stock Under $10**

• 

  10/4/2024

  **Thermo Fisher Scientific: Strong Company, Steep Price**

• 

  10/4/2024

  **Emergent BioSolutions: A Turnaround Opportunity**

• 

  10/4/2024

  **September 2024’s Top Stock Picks from 30 Expert Analysts**

• 

  10/3/2024

  **Iovance Biotherapeutics Enters New Phase**

• 

  10/3/2024

  **AI-Driven Platform Revolutionizes TL1A Drug Targeting**